These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2662827)

  • 1. Clinical experience with hepatitis B vaccines.
    West DJ
    Am J Infect Control; 1989 Jun; 17(3):172-80. PubMed ID: 2662827
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immune response to hepatitis B vaccine produced with genetic engineering].
    Ramón Torrell JM; Micheo Salas C; Cerdó Goicouria C; Casas García I; Escribá Jordana JM
    Rev Clin Esp; 1991 Feb; 188(2):68-71. PubMed ID: 2041902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current status and outlook of the artificial-active immunoprophylaxis of viral hepatitis B].
    Ivan A; Mitroi I
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(3):455-8. PubMed ID: 3074433
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity and safety of low doses of recombinant yeast-derived hepatitis B vaccine.
    Tan KL; Oon CJ; Goh KT; Wong LY; Chan SH
    Acta Paediatr Scand; 1990; 79(6-7):593-8. PubMed ID: 2143619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness and tolerance of genetically engineered vaccines for hepatitis B--a comparative study].
    Schmid K; Strebl H; Heck KJ; Weltle D; Raithel HJ
    Gesundheitswesen; 1992 May; 54(5):219-22. PubMed ID: 1535816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma-derived and yeast-derived hepatitis B vaccines.
    Ellis RW; Gerety RJ
    Am J Infect Control; 1989 Jun; 17(3):181-9. PubMed ID: 2662828
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B vaccine: extending immunogenicity.
    Horton RC
    Br J Hosp Med; 1990 Jun; 43(6):409. PubMed ID: 2364233
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma-derived versus recombinant hepatitis B vaccines.
    Kurtz JB; Alder MJ; Mayon-White RT; Juel-Jensen BE; Rodgers TM; Babic GM
    Lancet; 1989 Feb; 1(8635):451. PubMed ID: 2563836
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis B vaccines.
    N Z Med J; 1988 Dec; 101(859):831. PubMed ID: 2974517
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity and efficacy of anti-hepatitis B vaccines in hemodialysis patients.
    Dentico P; Volpe A; Buongiorno R; Maracchione N; Carbone M; Manno C; Proscia F
    Nephron; 1992; 61(3):324-5. PubMed ID: 1386904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunisation of staff of a regional blood transfusion centre with a recombinant hepatitis B vaccine.
    Rogan PD; Duguid JK
    J Infect; 1991 Jan; 22(1):5-9. PubMed ID: 1825836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New recommendations for immunization against pertussis and hepatitis B.
    Med Lett Drugs Ther; 1992 Jul; 34(875):69-71. PubMed ID: 1385851
    [No Abstract]   [Full Text] [Related]  

  • 14. Four-year experience with a recombinant hepatitis B vaccine.
    Jilg W; Schmidt M; Deinhardt F
    Infection; 1989; 17(2):70-6. PubMed ID: 2714860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines against hepatitis A and B.
    Zuckerman AJ
    Baillieres Clin Gastroenterol; 1990 Sep; 4(3):775-88. PubMed ID: 1962731
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis vaccines.
    Karayiannis P; Main J; Thomas HC
    Br Med Bull; 2004; 70():29-49. PubMed ID: 15339856
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of results of recombinant and plasma-derived hepatitis B vaccines in Japanese nursery-school children.
    Hayashi J; Kashiwagi S; Kajiyama W; Ikematsu H; Noguchi A; Nomura H; Ikeda K
    J Infect; 1988 Jul; 17(1):49-55. PubMed ID: 2974467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of an anti-hepatitis-B vaccination in a population at risk].
    Stellato M; Carbi S; Tosolini S
    Boll Ist Sieroter Milan; 1989; 68(1):34-41. PubMed ID: 2535244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults.
    Knöll A; Hottenträger B; Kainz J; Bretschneider B; Jilg W
    Vaccine; 2000 Apr; 18(19):2029-32. PubMed ID: 10706965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.